Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor ConferenceHANOVER, MD, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...
Globe Newswire•5 months ago